Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramideYuji Kondo, Kazutaka Ikeda, Noriyo Tokuda, et al.
The Journal of Biological Chemistry|August 27, 2017
Loss of mucin-type <i>O</i>-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidneyKai Song, Jianxin Fu, Jianhua Song, et al.
Journal of Proteome Research|March 17, 2009
Immunologic glycosphingolipidomics and NKT cell development in mouse thymusYunsen Li, Prakash Thapa, David Hawke, et al.
Biochemical and Biophysical Research Communications|November 11, 2008
Glycosphingolipids are not pivotal receptors for Subtilase cytotoxin in vivo: sensitivity analysis with glycosylation-defective mutant miceYuji Kondo, Noriyo Tokuda, Xiayan Fan, et al.
Cancer Research|March 4, 2015
Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progressionYumiko Yamamura, Naoya Asai, Atsushi Enomoto, et al.
World Journal of Gastroenterology|April 12, 2012
Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastographyRyota Masuzaki, Ryosuke Tateishi, Haruhiko Yoshida, et al.
Journal of Gastroenterology and Hepatology|August 30, 2014
Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patientsHayato Nakagawa, Naoto Fujiwara, Ryosuke Tateishi, et al.
International Journal of Cancer|December 21, 2010
Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patientsToru Arano, Hayato Nakagawa, Ryosuke Tateishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Comparison of improved prognosis between hepatitis B- and hepatitis C-related hepatocellular carcinomaTatsuya Minami, Ryosuke Tateishi, Shuichiro Shiina, et al.
Case Reports in Gastroenterology|January 24, 2013
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF SignalKazuya Okushin, Yoshinari Asaoka, Izumi Fukuda, et al.
Pageof 13